SuperworthEnsign profit margin ENSG
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- 6.9%
- Operating margin, 12 months
- 8.5%
- Net margin on a year earlier
- −0.1 pts
- Peer median
- 8.6%
Over the twelve months to Jun 30, 2026, Ensign kept 6.9% of its revenue as net profit, with an operating margin of 8.5% and a gross margin of 16.0%.
Five years earlier its net margin was 7.5%.
The median for 10 hospital and care facility stocks of a similar size is 8.6%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 6.8% | 8.4% | 15.8% |
| FY2024 | 7.0% | 8.4% | 18.2% |
| FY2023 | 5.6% | 6.8% | 21.1% |
| FY2022 | 7.4% | 9.8% | 17.1% |
| FY2021 | 7.4% | 9.9% | 23.1% |
| FY2020 | 7.1% | 9.3% | 22.4% |
| FY2019 | 5.4% | 6.3% | 20.4% |
| FY2018 | 4.5% | 6.3% | 20.2% |
| FY2017 | 2.2% | 4.4% | 19.0% |
| FY2016 | 3.0% | 5.6% | 18.9% |
| FY2015 | 4.1% | 6.9% | 20.4% |
| FY2014 | 3.5% | 7.1% | 19.9% |
| FY2013 | 2.7% | 6.4% | 19.7% |
| FY2012 | 4.9% | 9.5% | 20.3% |
| FY2011 | 6.3% | 12.0% | 20.8% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 6.9% | −0.1 pts | 8.5% | |
| Q1 FY26 | 6.9% | −0.1 pts | 8.5% | |
| Q4 FY25 | 6.8% | −0.2 pts | 8.4% | |
| Q3 FY25 | 6.8% | +1.0 pts | 8.3% | |
| Q2 FY25 | 7.0% | +1.3 pts | 8.6% | |
| Q1 FY25 | 7.0% | +1.3 pts | 8.5% | |
| Q4 FY24 | 7.0% | +1.4 pts | 8.4% | |
| Q3 FY24 | 5.8% | −1.1 pts | 6.8% | |
| Q2 FY24 | 5.7% | −1.4 pts | 6.8% | |
| Q1 FY24 | 5.7% | −1.7 pts | 6.8% | |
| Q4 FY23 | 5.6% | −1.8 pts | 6.8% | |
| Q3 FY23 | 7.0% | −0.3 pts | 8.6% |
Against its peers
Companies in Medical - Care Facilities nearest Ensign's size, closest first, today.
| Company | Profit margin |
|---|---|
| ENSGEnsign | 6.9% |
| UHSUniversal Health Services | 8.4% |
| DVADavita | 6.0% |
| BTSGBrightSpring Health Services | 2.5% |
| EHCEncompass Health | 10.0% |
| PACSPACS | 4.8% |
| CHEChemed | 10.6% |
| SHCSotera Health | 13.4% |
| CONConcentra Group Holdings Parent | 8.7% |
| LFSTLifeStance Health | 3.2% |
| THCTenet Healthcare | 10.3% |
| Peer median | 8.6% |
Where Ensign ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Ensign
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.